Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions

SIMPLE SUMMARY: The use of novel therapeutic drugs in lung cancer has changed the paradigm of the diagnosis and treatment of lung cancer. Due to the development of advanced diagnostic procedures (e.g., next generation sequencing (NGS)) around half of non-small-cell lung cancer (NSCLC) patients can b...

Descripción completa

Detalles Bibliográficos
Autores principales: Stencel, Katarzyna, Chmielewska, Izabela, Milanowski, Janusz, Ramlau, Rodryg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070470/
https://www.ncbi.nlm.nih.gov/pubmed/33921237
http://dx.doi.org/10.3390/cancers13081829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070470/
https://www.ncbi.nlm.nih.gov/pubmed/33921237
http://dx.doi.org/10.3390/cancers13081829

Ejemplares similares